Tufts Center for the Study of Drug Development

As industry stakeholders, we are always looking for trusted research, objective analysis, and industry insights in concise formats to help us stay informed. The Tufts CSDD bi-monthly Impact Report provides: ?? Charts and tables that present key points and synthesized analyses, while letting you focus on major strategic findings ?? Clear and concise bulleted takeaways that save you time deciphering extensive text ?? Explanatory sidebars and definitions to ensure a shared understanding of key concepts and terms Start your annual subscription today. Multi-reader programs are also available.?Visit https://lnkd.in/e7rQ8whb or contact Joan Chambers at [email protected]?

We’re live! ?? The new Tufts CSDD website is here—cleaner, smarter, and easier to use. Check it out and let us know what you think: https://csdd.tufts.edu/ Huge thanks to our Communications Coordinator Ava Feuer for directing this effort and to our developers Shady Hill Studios for creating the website of our dreams. #TuftsCSDD #NewWebsite #ImprovingClinicalResearch

Continued data collection and analysis are essential to refine our understanding of decentralized clinical trial (DCT) solutions and their impact on clinical research. By optimizing the use of DCTs and addressing potential challenges, the pharmaceutical industry can unlock their full potential—transforming clinical trials and improving patient outcomes. This aligns with the PACT Consortium’s mission to gather granular, actionable data on DCT impact. Join the PACT Consortium today to drive change and innovation within the clinical trials enterprise. Visit https://lnkd.in/ehsWfC-h today or connect with Joan Chambers to learn more. #DCT #ClinicalTrials #Patients #DigitalHealth #Diversity #ClinicalResearch, #Pharmaceutical #PatientOutcomes

Why are we revamping our website? Because you deserve a better way to access groundbreaking research and insights! ??? Here’s what you can expect: a refreshed look, a searchable, filterable publication archive, a new media center, and more! What excites you most? Launching Monday at 8:30 am EST ? #TuftsCSDD #WebsiteReLaunch #DrugDevelopment

The PACT Consortium collaborates to gather and analyze real-world data on DCT usage and solutions. Findings from Year 1 highlight key DCT applications in site and data management support: * 88% conduct virtual kick-off meetings * 83% utilize virtual training * 82% provide online tech support services * 69% implement online study monitoring Learn more about the PACT Consortium and gain insights into DCTs. Join as a member by visiting https://lnkd.in/ehsWfC-h today or connect with Joan Chambers. #DCT #ClinicalTrials #Patients #DigitalHealth #Diversity #RWD

?? Words Matter in Clinical Research – But Intent Matters More At Tufts CSDD, we recognize that terminology evolves, but our commitment to advancing scientific and operational excellence remains steadfast. From decentralized trials to diversity in clinical research, intent drives impact. ?? Our latest projects explore critical areas, including: ?? Transitioning from high-frequency to risk-based study monitoring ?? Patient and site participant burden in clinical trials ?? Study volunteer compensation and its impact on enrollment ?? AI and data-driven strategies shaping the future of drug development ?? Plus, we’re launching a new Tufts CSDD website soon, featuring an enhanced user experience and a filterable publications archive. Stay tuned! ?? Join the conversation, participate in our studies, and explore our latest insights https://lnkd.in/eXbaBHuZ #ClinicalResearch #DrugDevelopment #DecentralizedTrials #AccessibilityinResearch #ClinicalTrials

Pharma R&D is evolving—customization, costs, and complexity are increasing. Tufts CSDD’s Circle of Supporters is a dedicated member network committed to driving change with credible, data-backed insights and fostering meaningful conversations among stakeholders. Join the Circle of Supporters today and help shape the future of pharmaceutical innovation. Learn more about membership and its benefits: Visit https://lnkd.in/ecU4iKrP or connect with Joan Chambers.

Tufts CSDD’s most recent Impact Report focuses on the investigative site feasibility and qualification process and its contribution to rising study initiation timelines. The report also identifies opportunities to streamline and improve this process. To purchase this timely report or an annual subscription, visit https://lnkd.in/dSYX898E #SiteFeasibility #DrugDevelopment #ImpactReport

This Friday! Register now for this one! You won't want to miss it. Ken Getz will join other panelists Elisa Cascade, Jimmy Bechtel, MBA, Morgan Hanger, and Paul Ivsin. https://lnkd.in/gjKmfAgf Society for Clinical Research Sites (SCRS), Advarra, Continuum Clinical, A Spectrum Science Company, Clinical Trials Transformation Initiative (CTTI), Tufts Center for the Study of Drug Development

Optimizing DCT Solutions: The Road Ahead: Understanding how to continuously improve DCT methods for patient convenience, retention, and ease of participation. Collecting actionable data and addressing challenges to optimize these innovative solutions. Access the panel discussion recording from the Decentralized Trials & Research Alliance (DTRA) Annual 2024 Meeting in November moderated by Brandon Maggio of GSK, with industry experts Zachary Smith (Tufts CSDD), Christoph Hornik (Duke Clinical Research Institute), and Dr. Timil Patel (FDA). ?? https://lnkd.in/eQUR4fzJ #DecentralizedTrials #PatientAccess #ClinicalResearch #DCT